by 90TEN & Denovo Strategy for Sirtex
by firstlight Public Relations for Vifor Pharma UK
by 90TEN & Denovo Strategy for Sirtex
Improving access to SIRT in the UK
Bowel cancer that spreads to the liver is one of the biggest cancer killers in the UK and innovative solutions are needed that can offer extended survival for patients.
SIR-Spheres microspheres is a radiotherapy procedure that delivers millions of microscopic radioactive beads directly into tumours in the liver and can significantly extend life. With awareness of the procedure low, there was a clear need to educate patients and healthcare professionals about this life-extending treatment and to help them understand where and how they can access it.
By developing an integrated product campaign that mobilised clinical advocates, supported patients to tell their story and harnessed the power of the media, Sirtex, makers of SIR-Spheres, saw a dramatic increase in awareness among patient and clinicians and referrals for the procedure.
The clear, but simple, strategy we saw here ticked all the criteria boxes. Straight-forward, with SMART objectives and focused tactics they delivered impressive outcomes and clear benefits for patients. We liked the great transition between awareness, objectives and results in this truly integrated campaign. This could serve as best practice for what you can accomplish on a tight budget.
Entry deadline | 14 March 2019 |
Extended entry deadline | 21 March 2019 |
Judging days | 9 May and 23 May 2019 |
Awards Ceremony | 4 July 2019 |
For sponsorship opportunities:
Sales Team
sales@pmlive.com
Tel: +44 (0)1372 414200
General event enquiries:
Debbie Tuesley
dtuesley@pmlive.com
Tel: +44 (0)1372 414243